Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

FDA OKs New Keytruda Shot for Cancer

The F.D.A. approved Merck’s injected version of its blockbuster infusion Keytruda. The company says it will be quicker and easier, but it stands to slow the adoption of cheaper competitors and increase costs by billions of dollars.

Rebecca Robbins
Author: Rebecca Robbins

Written by

Rebecca Robbins

in

Cancer, Drugs (Pharmaceuticals), Food and Drug Administration, Health Insurance and Managed Care, Immunotherapy, Inventions and Patents, Medicare, Merck & Company Inc, Prices (Fares, Fees and Rates)
←Trump Has In-Air Meltdown Over Talk Show Hosts Trashing Him
Ex-Disney CEO Rips ABC Call To Pull Kimmel Off Air: ‘Where Has All The Leadership Gone?’→

More posts

  • How Uruguay built a national care system from the ground up

  • Ask Jordan: What can Congress do about gerrymandering that the Supreme Court would allow?

  • South Korea catches 111 students with new measures against exam cheating

  • Cummins retains Cricket Australia support as captain

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube